• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喜树碱包封到功能化的 MCM-41 中:体外释放研究、细胞毒性和动力学。

Camptothecin encapsulated into functionalized MCM-41: In vitro release study, cytotoxicity and kinetics.

机构信息

Department of Chemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, Gujarat, India.

Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390002, Gujarat, India.

出版信息

Mater Sci Eng C Mater Biol Appl. 2019 May;98:1014-1021. doi: 10.1016/j.msec.2019.01.065. Epub 2019 Jan 16.

DOI:10.1016/j.msec.2019.01.065
PMID:30812985
Abstract

The application of MCM-41 functionalized by 12-tungstophosphoric acid (TPA) as drug carrier for cancer treatment was studied by loading of camptothecin (CPT). In-vitro controlled release study of CPT in Simulated Body Fluid (pH 7.4, 37 °C) was carried out under stirring as well as static conditions. The systems were also evaluated on cancer cells (HepG2) and the carriers are found to be non-toxic to the cancer cells. In order to see the influence of inorganic moiety on release rate of drug, study was also carried out with CPT loaded unfunctionalized MCM-41. A detailed study on release kinetics and release mechanism using First Order Release Kinetic Model, Higuchi Model, Koresmeyer-Pepps Model and Extended kinetic model was also carried out.

摘要

研究了用 12-钨磷酸(TPA)功能化的 MCM-41 作为载体制备喜树碱(CPT)的应用,以用于癌症治疗。在搅拌和静态条件下,在模拟体液(pH 7.4,37°C)中进行了 CPT 的体外控制释放研究。还在肝癌细胞(HepG2)上评估了这些系统,发现载体对癌细胞无毒。为了观察无机部分对药物释放速率的影响,还进行了载有未功能化 MCM-41 的 CPT 的研究。还使用一级释放动力学模型、Higuchi 模型、Koresmeyer-Pepps 模型和扩展动力学模型对释放动力学和释放机制进行了详细研究。

相似文献

1
Camptothecin encapsulated into functionalized MCM-41: In vitro release study, cytotoxicity and kinetics.喜树碱包封到功能化的 MCM-41 中:体外释放研究、细胞毒性和动力学。
Mater Sci Eng C Mater Biol Appl. 2019 May;98:1014-1021. doi: 10.1016/j.msec.2019.01.065. Epub 2019 Jan 16.
2
Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.硅醚喜树碱从硫醇-烯点击化学功能化介孔二氧化硅纳米颗粒中的控释。
Acta Biomater. 2017 Mar 15;51:471-478. doi: 10.1016/j.actbio.2017.01.062. Epub 2017 Jan 25.
3
Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.载药介孔硅纳米结构用于香豆素衍生物的控制释放:一种新型的热疗效果测试。
Eur J Pharm Biopharm. 2011 Jan;77(1):66-74. doi: 10.1016/j.ejpb.2010.10.007. Epub 2010 Oct 23.
4
The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.作为水不溶性西洛他唑的口服固体分散体载体的 MCM-48 型和 MCM-41 型介孔硅的研究。
Drug Dev Ind Pharm. 2014 Jun;40(6):819-28. doi: 10.3109/03639045.2013.788013. Epub 2013 Apr 17.
5
Design of enzyme-mediated controlled release systems based on silica mesoporous supports capped with ester-glycol groups.基于接枝酯-二醇基团的硅质介孔载体的酶介导控制释放体系的设计。
Langmuir. 2012 Oct 16;28(41):14766-76. doi: 10.1021/la303161e. Epub 2012 Oct 3.
6
Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery.氧化还原敏感脂质喜树碱偶联物包封的固体脂质纳米粒口服递药系统。
Int J Pharm. 2018 Oct 5;549(1-2):352-362. doi: 10.1016/j.ijpharm.2018.08.010. Epub 2018 Aug 9.
7
Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.介孔硅 MCM-41 和 MCM-48 裸粒及功能化颗粒的体外渗透性能和体内药代动力学行为研究:雷洛昔芬的突释和控释给药系统。
Drug Dev Ind Pharm. 2019 Apr;45(4):587-602. doi: 10.1080/03639045.2019.1569028. Epub 2019 Feb 4.
8
Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.载甲氨蝶呤介孔 MCM-41 纳米粒处方变量的研究——提高溶解度。
Eur J Pharm Sci. 2012 Jan 23;45(1-2):8-18. doi: 10.1016/j.ejps.2011.10.016. Epub 2011 Oct 31.
9
Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.高效槲皮素传递系统的制备:Zn 改性介孔 SBA-15 硅载体。
Mater Sci Eng C Mater Biol Appl. 2017 Apr 1;73:285-292. doi: 10.1016/j.msec.2016.12.063. Epub 2016 Dec 18.
10
Camptothecin: solubility, in-vitro drug release, and effect on human red blood cells and sperm cold preservation.喜树碱:溶解度、体外药物释放以及对人红细胞和精子低温保存的影响。
Cryo Letters. 2023 Mar-Apr;44(2):89-99.

引用本文的文献

1
Chemical characterization and encapsulation of extract with cytotoxic properties.具有细胞毒性的提取物的化学表征与包封
Front Pharmacol. 2025 Jan 23;16:1526502. doi: 10.3389/fphar.2025.1526502. eCollection 2025.
2
Cellulose Acetate Microparticles Synthesized from Perrine for Controlled Release of Simvastatin.由佩林合成的用于辛伐他汀控释的醋酸纤维素微粒。
Polymers (Basel). 2024 Jul 2;16(13):1898. doi: 10.3390/polym16131898.
3
Kinetics and Mechanism of Camptothecin Release from Transferrin-Gated Mesoporous Silica Nanoparticles through a pH-Responsive Surface Linker.
喜树碱通过pH响应性表面连接子从转铁蛋白门控介孔二氧化硅纳米颗粒中释放的动力学及机制
Pharmaceutics. 2023 May 25;15(6):1590. doi: 10.3390/pharmaceutics15061590.
4
In Situ Encapsulation of Camptothecin by Self-Assembly of Poly(acrylic acid)--Poly(-Isopropylacrylamide) and Chitosan for Controlled Drug Delivery.通过聚(丙烯酸)-聚(N-异丙基丙烯酰胺)和壳聚糖的自组装实现喜树碱的原位包封用于药物控释。
Polymers (Basel). 2023 May 26;15(11):2463. doi: 10.3390/polym15112463.
5
Effect of Surface Property on the Release and Oral Absorption of Solid Sirolimus-Containing Self-microemulsifying Drug Delivery System.表面特性对含固体西罗莫司自微乳药物传递系统的释放和口服吸收的影响。
AAPS PharmSciTech. 2021 Mar 14;22(3):108. doi: 10.1208/s12249-021-01978-z.